earnings
confidence high
sentiment neutral
materiality 0.55
Ainos Q1 2026: operating expenses down 30% to $2.28M, secures $2.8M financing, progresses AI Nose deployments
Ainos, Inc.
2026-Q1 EPS reported
-$0.41
revenue$161
- Operating expenses declined ~30% YoY to approximately $2.28 million for Q1 2026.
- Strengthened balance sheet with NT$90 million (~$2.8 million) financing arrangement during the quarter.
- Continued deployment under $2.1M commercial arrangement in backend semiconductor environments targeting ~1,400 AI Nose systems.
- Initiated pilot and validation activities in front-end semiconductor environments and expanded distribution partnership.
- Expanded AI Nose into healthcare infrastructure settings including hospital utility, HVAC, and MRI environments.